While all of ENDO 2026 sessions are can’t miss events, certain ones almost always inspire certain passions among the attendees, and those are the debates! Former Endocrine Society president Stephen Hammes, MD, PhD, moderated the Endocrine Debate session “ Low Testosterone in Obesity: Should We Treat or Not?” and Kelly Horvath has taken a deep dive in “ To T or Not To T: Should We Treat Low Testosterone in Men with Obesity? ” Joining Hammes to debate are Franck Mauvais-Jarvis, MD, PhD, professor of medicine, Price-Goldsmith Professor of Nutrition, Tulane University School of Medicine, in New Orleans, La., who argues for the treat side, while David Handelsman, MBBS, PhD, FRACP, of the ANZAC Research Institute at the University of Sydney, in Australia, argues the opposite.
Endocrine News published a clinical update in Research Highlights on 25 Jun 2026.
The item focuses on Breezing Into the Windy City for ENDO 2026.
Review the original article for the full source wording and details.